Profile
Full Name
Halozyme Therapeutics, Inc.Ticker Symbol
HALOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 16, 2004Indexes
Not includedWebsite
http://halozyme.comEmployees
350Key Details
Price
$63.00
Market Cap
$7.76B(Mid cap)
Last Dividend
-
TTM Dividend Yield
-
Annual Revenue
$1.02B(+22.44% YoY)
Annual EPS
$3.43(+63.33% YoY)
PE Ratio
18.37
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Halozyme Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 6, 25 HC Wainwright & Co.
BuyFeb 20, 25 Benchmark
BuyFeb 19, 25 HC Wainwright & Co.
BuyFeb 4, 25 HC Wainwright & Co.
BuyJan 13, 25 Wells Fargo
Equal-WeightJan 10, 25 Piper Sandler
NeutralJan 10, 25 HC Wainwright & Co.
BuyDec 30, 24 HC Wainwright & Co.
BuyDec 18, 24 HC Wainwright & Co.
BuyNov 25, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Halozyme Therapeutics?
- Does Halozyme Therapeutics pay dividends?
- What sector is Halozyme Therapeutics in?
- What industry is Halozyme Therapeutics in?
- What country is Halozyme Therapeutics based in?
- When did Halozyme Therapeutics go public?
- Is Halozyme Therapeutics in the S&P 500?
- Is Halozyme Therapeutics in the NASDAQ 100?
- Is Halozyme Therapeutics in the Dow Jones?
- When was Halozyme Therapeutics's last earnings report?
- When does Halozyme Therapeutics report earnings?
- Should I buy Halozyme Therapeutics stock now?
What is the ticker symbol for Halozyme Therapeutics?
The ticker symbol for Halozyme Therapeutics is NASDAQ:HALO
Does Halozyme Therapeutics pay dividends?
No, Halozyme Therapeutics does not pay dividends
What sector is Halozyme Therapeutics in?
Halozyme Therapeutics is in the Healthcare sector
What industry is Halozyme Therapeutics in?
Halozyme Therapeutics is in the Biotechnology industry
What country is Halozyme Therapeutics based in?
Halozyme Therapeutics is headquartered in United States
When did Halozyme Therapeutics go public?
Halozyme Therapeutics's initial public offering (IPO) was on March 16, 2004
Is Halozyme Therapeutics in the S&P 500?
No, Halozyme Therapeutics is not included in the S&P 500 index
Is Halozyme Therapeutics in the NASDAQ 100?
No, Halozyme Therapeutics is not included in the NASDAQ 100 index
Is Halozyme Therapeutics in the Dow Jones?
No, Halozyme Therapeutics is not included in the Dow Jones index
When was Halozyme Therapeutics's last earnings report?
Halozyme Therapeutics's most recent earnings report was on Feb 18, 2025
When does Halozyme Therapeutics report earnings?
The next expected earnings date for Halozyme Therapeutics is May 7, 2025
Should I buy Halozyme Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions